Nova Eye Medical Limited
ELXMF
$0.00
-$0.10-98.10%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.53M | -5.18M | -5.89M | -5.76M | -5.65M |
| Total Depreciation and Amortization | 1.39M | 1.42M | 1.45M | 1.71M | 1.97M |
| Total Amortization of Deferred Charges | 39.60K | 24.80K | 16.00K | -80.40K | -180.20K |
| Total Other Non-Cash Items | 296.40K | 528.10K | 766.00K | 562.10K | 361.70K |
| Change in Net Operating Assets | -337.90K | -337.90K | -337.90K | -816.00K | -1.30M |
| Cash from Operations | -3.14M | -3.55M | -4.00M | -4.39M | -4.79M |
| Capital Expenditure | -219.80K | -205.10K | -191.50K | -131.40K | -72.70K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -41.40K | -42.00K | -43.00K | -36.60K | -30.40K |
| Cash from Investing | -261.10K | -247.00K | -234.30K | -167.90K | -103.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -649.00K | -631.00K | -613.00K | -574.50K | -536.00K |
| Issuance of Common Stock | 6.17M | 6.17M | 6.17M | 6.80M | 7.43M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 3.49M | 3.50M | 3.51M | 4.01M | 4.54M |
| Foreign Exchange rate Adjustments | 85.20K | 100.00 | -82.90K | 16.80K | 114.40K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 179.50K | -290.80K | -799.40K | -529.20K | -242.80K |